We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company said it will continue to manufacture the patch at its Israeli facilities and through a certified medical devicemaker in the same country. Read More
Orfit previously received FDA clearance in 2015 for an immobilization system for patients with brain, head and neck tumors for use during proton therapy. Read More
The device allows physicians to offer an array of waveforms across the SCS frequency spectrum, either on their own or paired with the company’s HF10 electrical-pulse therapy. Read More